M3, Inc. (2413):企業の財務・戦略的SWOT分析

◆英語タイトル:M3, Inc. (2413) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1370
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

M3, Inc. (2413) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

M3 Inc (M3) is a provider of medical related services through the use of the Internet. The company offers medical-related services to pharmaceutical and other medical-related companies, physicians and healthcare professionals, and the general public. It provides wide range of service online using website portals including AskDoctors, Ichie, MR-kun, MEDI: GATE, and MDLinx, and iTicket Plus. It was formed under the service name of So-net, with Sony Communications Network Corporation, a supplier of network-related services, as the largest stockholder. M3 represents the three M’s of medicine, media, and metamorphosis. The company, together with its subsidiaries and affiliates, operates in the US, Europe, South Korea, Spain, France, India, Germany and Japan. M3 is headquartered in Minato-ku, Tokyo, Japan.

M3, Inc. Key Recent Developments

Dec 19,2019: Beta Launch of LINE Healthcare, a Consumer Healthcare Platform

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
M3, Inc. – Key Facts
M3, Inc. – Key Employees
M3, Inc. – Major Products and Services
M3, Inc. – History
M3, Inc. – Company Statement
M3, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Section 2 – Company Analysis
Company Overview
M3, Inc. – Business Description
Business Segment: Career Solution
Overview
Performance
Business Segment: Evidence Solution
Overview
Performance
Business Segment: Medical Platform
Overview
Performance
Business Segment: Other Emerging Businesses
Overview
Performance
Business Segment: Overseas
Overview
Performance
M3, Inc. – SWOT Analysis
SWOT Analysis – Overview
M3, Inc. – Strengths
M3, Inc. – Weaknesses
M3, Inc. – Opportunities
M3, Inc. – Threats
M3, Inc. – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
M3, Inc., Recent Deals Summary
Section 4 – Company’s Recent Developments
Dec 19, 2019: Beta Launch of LINE Healthcare, a Consumer Healthcare Platform
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
M3, Inc., Key Facts
M3, Inc., Key Employees
M3, Inc., Major Products and Services
M3, Inc., History
M3, Inc., Subsidiaries
M3, Inc., Affiliate
M3, Inc., Key Competitors
M3, Inc., Ratios based on current share price
M3, Inc., Annual Ratios
M3, Inc., Annual Ratios (Cont...1)
M3, Inc., Annual Ratios (Cont...2)
M3, Inc., Interim Ratios
M3, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
M3, Inc., Performance Chart (2015 - 2019)
M3, Inc., Ratio Charts

★海外企業調査レポート[M3, Inc. (2413):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Navid Zar Chimi Ind Co:企業の戦略的SWOT分析
    Navid Zar Chimi Ind Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …
  • Viavi Solutions Inc
    Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Viavi Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Aragen Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process de …
  • Autoridad del Canal de Panama:企業の戦略的SWOT分析
    Autoridad del Canal de Panama - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Antrim Energy Inc. (AEN)-石油・ガス分野:企業M&A・提携分析
    Summary Antrim Energy Inc. (Antrim Energy) is an oil and gas exploration and production company. It conducts the acquisition, exploration, development and production of oil and natural gas properties. The company carries out its operations in the UK North Sea and Ireland. In UK, the company holds op …
  • Sysmex America Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sysmex America Inc (Sysmex America), a subsidiary of Sysmex Corp is a medical device company that manufactures laboratory testing equipments. The company's products include clinical diagnostic devices, in vitro diagnostic hematology devices, urinalysis devices, reagents and information syste …
  • Quaker Chemical Corp (KWR):企業の財務・戦略的SWOT分析
    Quaker Chemical Corp (KWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pharmaceutics International Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pharmaceutics International Inc (PII) is a contract development and manufacturing company that offers dosage form development and cGMP manufacturing services. The company offers manufacturing of drugs such as dosage forms of solid, semi-solid, liquid, inhalation, parenteral and aseptic filli …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422):医療機器:M&Aディール及び事業提携情報
    Summary Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compoun …
  • Western Power Distribution Plc:企業の戦略的SWOT分析
    Western Power Distribution Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • ReNeuron Group Plc (RENE):企業の財務・戦略的SWOT分析
    ReNeuron Group Plc (RENE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Evonik Industries AG:企業のM&A・事業提携・投資動向
    Evonik Industries AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evonik Industries AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • PROS Holdings Inc (PRO):企業の財務・戦略的SWOT分析
    Summary PROS Holdings Inc (PROS) is an information technology company that offers profitability management and optimization software solutions. The company's products include Selling PRO, Pricing PRO, Revenue PRO and Pros for CRM. Its Selling PRO software comprises e-commerce, Smart CPQ and Deal des …
  • Seegene Inc (096530):企業の財務・戦略的SWOT分析
    Summary Seegene Inc (Seegene) is a diagnostic company that develops molecular diagnostic reagents. The company provides products such as seeplex, anyplex and magicplex among others. It develops ACP, DPO, READ, MuDT and TOCE technologies that enables to detect multiple pathogens in single reactions u …
  • Egdon Resources Plc (EDR):企業の財務・戦略的SWOT分析
    Summary Egdon Resources Plc (Egdon) is oil and gas company that offers exploration and production services. The company explores and develops petroleum and natural gas assets in East Midlands, North East England, North West England, and Southern England, the UK. Its project site includes Wressle, No …
  • Teekay Corp (TK):企業の財務・戦略的SWOT分析
    Teekay Corp (TK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Westar Energy Inc (WR)-エネルギー分野:企業M&A・提携分析
    Summary Westar Energy, Inc. (Westar Energy) is a vertically integrated energy utility that generates, transmits and distributes electricity. The company owns and operates a generation portfolio of coal-fired, nuclear, natural gas-based, renewable and diesel-based power plants. It also procures elect …
  • FibroGen Inc (FGEN)-製薬・医療分野:企業M&A・提携分析
    Summary FibroGen Inc (FibroGen) is a biotechnology company that discovers, develops and commercializes new therapeutics. The company’s pipeline product portfolio includes FG-4592, an oral small molecule inhibitor of HIF prolyl hydroxylases that is used for the treatment of anemia in chronic kidney d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆